Cognitive function dynamics in comorbid patients after angioreconstructive interventions

Angioreconstructive interventions are generally known to be of prophylactic value for cerebrovascular diseases (CVD). At the same time, their prognosis in comorbid patients, particularly in those with type 2 diabetes (T2D), have been insufficiently covered.

Objective: to study the impact of T2D on cognitive functions after carotid angioplasty with stenting (CAS)

Patients and methods. CAS was performed in 99 patients with chronic CVD. Group 1 consisted of 51 patients (median age, 64.5 years) without carbohydrate metabolism disorders. Group 2 included 48 patients (median age, 64 years) with T2D. Over time, all the patients underwent clinical, neurological, and neuropsychological examinations, general clinical and biochemical blood tests, duplex scanning of the brachiocephalic arteries, and magnetic resonance imaging (MRI) of the brain. Blood flow in the middle cerebral artery was monitored to assess the embolic and hemodynamic situation during a CAS procedure.

Results and discussion. The baseline frequency of neurocognitive impairment was almost the same (75%) in both groups; however, the impairment was more obvious in patients with T2D. Re-examination in Group 1 patients immediately after intervention revealed slight positive cognitive changes, while the patients with T2D showed a decrease in the indicators of mental functions. The improved ability to abstract and increase the level of generalization of functions appeared in T2D patients only 2 months after intervention. Post-CAS MRI revealed ipsilateral acute ischemic foci (AIF) in the brain substance in 11 (22%) patients of Group 1 and in 24 (50%) with concomitant T2D. Comparison of neuroimaging data with cognitive function assessments for the entire group of the examinees established deterioration in the cognitive status in patients with new ischemic brain changes detected after intervention.

Conclusion. CVD concurrent with T2D usually contributes to deterioration in the cognitive status. Angioreconstructive interventions, in particular CAS, are frequently accompanied by the identification of AIF (including «silent» ones) that can cause a transient deterioration in cognitive functions. When planning angioreconstructive interventions in patients with T2D, the question arises of predicting such risks and possible neuroprotective methods.

1. Benjamin EJ, Muntner P, Alonso A, et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2019 update: a report from the American Heart Association. Circulation. 2019;139:e56-e528.

2. American Diabetes Association – 2018. Cardiovascular disease and risk management: standards of medical care in diabetes-2018. Diabetes Care. 2018;41:S86-S104. doi: 10.2337/dc18-S009

3. Tanashyan MM, editor. Sosudistye zabolevaniya golovnogo mozga i metabolicheskij sindrom. Rukovodstvo dlya vrachej [Vascular diseases of the brain and metabolic syndrome. A guide for doctors]. Moscow: AST 345; 2017. 334 p. (In Russ.).

4. Reaven GM. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. Panminerva Med. 2005;47(4):201-10.

5. Gujjar AR. Diabetes and Stroke: More than just accelerated atherosclerosis? Sultan Qaboos Univ Med J. 2018 Aug;18(3):e261-e263. doi: 10.18295/squmj.2018.18.03.001. Epub 2018 Dec 19.

6. Tanashyan ММ, Lagoda OV, Antonova KV, Raskurazhev AA, Chatskaya AV. Cognitive dysfunction in patients with cerebrovascular disease and diabetes. Klinicheskaya farmakologiya i terapiya = Clinical Pharmacology and Therapy. 2017;26(5):25-30 (In Russ.).

7. Dumont TM, Rughani AI. National trends in carotid artery revascularization surgery. J Neurosurg. 2012 Jun;116(6):1251-7. doi: 10.3171/2012.3.JNS111320. Epub 2012 Apr 6.

8. Yadav JS, Wholey MH, Kuntz RE, et al. Stenting and angioplasty with protection in patients at high risk for endarterectomy investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004 Oct 7;351(15):1493-501. doi: 10.1056/NEJMoa040127

9. Kuntcevich GI, Tanashyan MM, Scrylev SI, et al. Intraoperative monitoring of cerebral blood-flow and condition of cerebral at open and endovascular interventions in carotid system. Angiologiya i sosudistaya khirurgiya = Angiology and Vascular Surgery. 2011;17(3):43-8 (In Russ.).

10. Hitchner E, Baughman BD, Soman S. Microembolization is associated with transient cognitive decline in patients undergoing carotid interventions. J Vasc Surg. 2016 Dec;64(6):1719-25. doi: 10.1016/j.jvs.2016.06.104. Epub 2016 Sep 12.

11. Zhou W, Baughman BD, Soman S, et al. Volume of subclinical embolic infarct correlates to longterm cognitive changes after carotid revascularization. J Vasc Surg. 2017 Mar;65(3):686-94. doi: 10.1016/j.jvs.2016.09.057. Epub 2016 Dec 23.

12. Tanashyan MM, Antonova KV, Medvedev RB, et al. Symptomatic and silent cerebral ischemia (detected on MRI) in patients with type 2 diabetes mellitus after carotid revascularization procedures. Sakharnyi diabet = Diabetes Mellitus. 2019;22(1):14-24. doi: 10.14341/DM9633 (In Russ.).

13. Yakhno NN, Zakharov VV. Vascular cognitive impartments. Russkii meditsinskii zhurnal. 2005;12:789-93 (In Russ.).

14. De Rango P, Caso V, Leys D, et al. The role of carotid artery stenting and carotid endarterectomy in cognitive performance. A systematic review. Stroke. 2008;39:3116-27. doi: 10.1161/STROKEAHA.108.518357

15. Siddiqui AH, Hopkins LN. Asymptomatic carotid stenosis: the not-so-silent disease changing perspectives from thromboembolism to cognition. J Am Coll Cardiol. 2013 Jun 25;61(25):2510-3. doi: 10.1016/j.jacc.2013.01.087. Epub 2013 Apr 3.

16. Huang CC, Chen YH, Lin MS. Association of the recovery of objective abnormal cerebral perfusion with neurocognitive improvement after carotid revascularization. J Am Coll Cardiol. 2013;61:2503-9. doi: 10.1016/j.jacc.2013.02.059

17. Chen YH, Lin MS, Lee JK, et al. Carotid stenting improves cognitive function in asymptomatic cerebral ischemia. Int J Cardiol. 2012 May 17;157(1):104-7. doi: 10.1016/j.ijcard.2011.10.086. Epub 2011 Nov 16.

18. Mlekusch W, Mlekusch I, Haumer M, et al. Improvement of neurocognitive function after protected carotid artery stenting. Catheter Cardiovasc Interv. 2008;71:114-9. doi: 10.1002/ccd.21407

19. Tani N, Yaegaki T, Nishino A. Functional connectivity analysis and prediction of cognitive change after carotid artery stenting. J Neurosurg. 2018 Dec 14;131(6):1709-15. doi: 10.3171/2018.7.JNS18404

20. Tanashyan MM, Medvedev RB , Lagoda OV, et al. The state of cognitive functions after angioreconstructive operations on the carotid arteries. Vestnik RGMU. 2019;(5):70-7. doi: 10.24075/vrgmu.2019.059 (In Russ.).

21. Yakhno NN, Fedorova TS, Damulin IV, et al. The effect of carotid endarterectomy on cognitive disturbances in patients with atherosclerotic stenosis of carotid arteries. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2011;111(3):31-7 (In Russ.).

22. Barber PA, Hach S, Tippett LJ, et al. Cerebral ischemic lesions on diffusion-weighted imaging are associated with neurocognitive decline after cardiac surgery. Stroke. 2008 May;39(5):1427-33. doi: 10.1161/STROKEAHA.107.502989. Epub 2008 Mar 6.

23. Kraemer C, Nisson P, Wheeler G, et al. Patient risk factors associated with embolic stroke volumes following revascularization. J Vasc Surg. 2020 Apr 3;S0741-5214(20)30467-5. doi: 10.1016/j.jvs.2020.02.040. Online ahead of print.

24. Cukierman-Yaffe T, Gerstein HC, Williamson JD, et al. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care. 2009;32(2):221-6. doi: 10.2337/dc08-1153